Skip to main content
Bodal Chemicals Ltd logo

Bodal Chemicals Ltd — Investor Relations & Filings

Ticker · BODALCHEM ISIN · INE338D01028 LEI · 33580055P81L7PGHUJ40 BSE.NS Manufacturing
Open in API
Filings indexed 1,550 across all filing types
Latest filing 2022-02-11 Regulatory Filings
Country IN India
Listing BSE.NS BODALCHEM

About Bodal Chemicals Ltd

https://www.bodal.com/

Bodal Chemicals Ltd is a vertically integrated manufacturer specializing in dyestuffs, dye intermediates, and basic chemicals. The product portfolio includes a wide range of reactive, acid, and direct dyes, alongside key intermediates such as H-Acid and Vinyl Sulphone. The chemical division produces sulfuric acid, chloro sulfonic acid, and liquid sulfur trioxide. By maintaining a high degree of backward integration, the company ensures cost-efficiency and consistent quality across its manufacturing chain. It serves diverse global markets, primarily catering to the textile, leather, paper, and plastic sectors. The organization focuses on large-scale production capabilities and technical expertise to provide chemical solutions for industrial applications worldwide.

Recent filings

Filing Released Lang Actions
Bodal Chemicals Limited has informed the Exchange regarding Board meeting held on February 11, 2022.
Regulatory Filings
2022-02-11 English
Bodal Chemicals herewith submit Financial Results for Quarter and nine months ended 31st December 2021 and outcome of Board Meeting.
Regulatory Filings
2022-02-11 English
Financial Result Updates
Regulatory Filings
2022-02-11 English
Bodal Chemicals Limited has informed the Exchange about Schedule of Con Call
Regulatory Filings
2022-02-09 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an announcement of an upcoming earnings/conference call for Q3 FY22 by Bodal Chemicals Ltd. It includes details about the call timing, dial-in numbers, and participants but does not contain any actual financial results or substantive financial data. The document is relatively short (4224 characters) and serves as an invitation and notification rather than a report or transcript. Therefore, it fits the definition of a Call Transcript (CT) only if it contained the full transcript, but here it is only an announcement of the call. Hence, the correct classification is Call Transcript (CT) if it were the transcript, but since this is an announcement of the call, it is best classified as Regulatory Filings (RNS) as a general regulatory announcement about the earnings call. However, given the options and the document content, the best fit is Call Transcript (CT) because it is about the earnings call and includes details for participation, which is typical for call transcripts or announcements related to calls. But since it is not the transcript itself, the fallback is Regulatory Filings (RNS). Confidence is high due to clear mention of earnings call and no financial data included.
2022-02-09 English
BODAL CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2022 ,inter alia, to consider and approve financial results for the ....
Regulatory Filings
2022-02-04 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.